Top Markets
#1 Threshold Network Threshold Network +48.26%
#2 TENDIES TENDIES +47.46%
#3 Mubarak Mubarak +19.04%
#4 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#5 OSK OSK +16.18%
#6 Kinetiq Kinetiq +15.12%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 MultiversX MultiversX +11.47%
#9 Maple Finance Maple Finance +11.12%
#10 Magma Finance Magma Finance +10.48%
Coin of the day
Threshold Network Threshold Network
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Healios K.K. Healios K.K.

Healios K.K.

4593
Pozycja w akcjach #17189
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011,... Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Cena akcji
$1.89
Kapitalizacja rynkowa
$254.55M
Zmiana (1 dzień)
-2.03%
Zmiana (1 rok)
-48.53%
Kraj
JP
Handel Healios K.K. (4593)

Kategoria

Healthcare
Historia ceny akcji dla Healios K.K. (4593)
Najwyższa cena zamknięcia: $1.91 dnia 2026-09-01

Najniższa cena zamknięcia: $12.24 dnia 2015-06-01
Historia cen akcji firmy Healios K.K. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 10.25%
2025 88.62%
2024 -2.29%
2023 -42.34%
2022 -81.62%
2021 -40.66%
2020 45.21%
2019 -16.02%
2018 2.08%
2017 -12.10%
2016 85.34%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $550.79 37.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.18%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $147.97 511.69%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH